Procedure
Transoral Robotic Surgery (TORS)
Transoral Robotic Surgery (TORS) is a medical procedure with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (66.7%)
N/A1 (33.3%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer
NCT03107182
terminatedphase_2
Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
NCT02225496
completed
Local Control After Robot-assisted Supraglottic Laryngectomy
NCT03357107
completednot_applicable
Transoral Robotic Surgery (TORS) for Sleep Apnea
NCT01187160
Clinical Trials (4)
Showing 4 of 4 trials
NCT03107182Phase 2
Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer
NCT02225496Phase 2
Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
NCT03357107
Local Control After Robot-assisted Supraglottic Laryngectomy
NCT01187160Not Applicable
Transoral Robotic Surgery (TORS) for Sleep Apnea
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4